Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of PF-06650833 at 12 weeks, in subjects with moderate - severe active RA who have had an inadequate response to methotrexate. Evaluar la eficacia de PF-06650833 a las 12 semanas, en sujetos con AR active moderada-severa con inadecuada respuesta a metotrexato.
Critère d'inclusion
- Rheumatoid Arthritis,Aritritis reumatoide